Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Urology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Urology

Journal Scan / Research · July 26, 2020

Underestimation of PET/CT in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence

The Journal of Urology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Urology
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections
J Urol 2020 Aug 01;204(2)296-302, N Fossati, S Scarcella, G Gandaglia, N Suardi, D Robesti, L Boeri, RJ Karnes, A Heidenreich, D Pfister, A Kretschmer, A Buchner, C Stief, A Battaglia, S Joniau, H Van Poppel, D Osmonov, KP Juenemann, S Shariat, A Hiester, A Nini, P Albers, D Tilki, M Graefen, IS Gill, A Mottrie, AB Galosi, F Montorsi, A Briganti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading